Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
YOKNEAM, ISRAEL--(Marketwired - Mar 21, 2014) - Lumenis Ltd. (NASDAQ: LMNS), the world's largest medical laser company for aesthetic, surgical and ophthalmic applications, announced today the...
-
SOPHIA ANTIPOLIS, France, March 17, 2014 (GLOBE NEWSWIRE) -- Nicox S.A. (NYSE Euronext Paris: COX) today announced the European launch of Xailin(TM), a new range of tear lubricants (medical devices)...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Nicox launches AdenoPlus® and Xailin(TM) dry eye...
-
NEWARK, Calif., March 12, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} EASTPHARMA LTD. London, 10 March 2014 -...
-
Near-Term Clinical Catalysts: • Viral Conjunctivitis Trial Results to be Reported mid-2014 • Start of Second Phase 2 in UCBE...
-
BOSTON, MA--(Marketwired - Mar 6, 2014) - Fueled by point-of-care (POC) technologies, the health care industry is headed for transformative change toward a patient-centric model. The near-term...
-
NEW YORK, March 6, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today that it has entered into a...
-
Liestal, Schweiz, 4. März, 2014 - Santhera Pharmaceuticals (SIX: SANN) gibt heute bekannt, neue Daten aus dem Expanded-Access-Programm (EAP) mit Raxone® zur Behandlung von Leber Hereditärer...
-
Liestal, Switzerland, March 4, 2014 - Santhera Pharmaceuticals (SIX: SANN) announced today that it will present data from its ongoing Expanded Access Program (EAP) with Raxone® in the treatment of...